According to LeMaitre Vascular's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 7.26452. At the end of 2023 the company had a P/S ratio of 6.53.
Year | P/S ratio | Change |
---|---|---|
2023 | 6.53 | 4.27% |
2022 | 6.26 | -11.82% |
2021 | 7.10 | 11.54% |
2020 | 6.37 | 3.03% |
2019 | 6.18 | 40.77% |
2018 | 4.39 | -27.79% |
2017 | 6.08 | 15.13% |
2016 | 5.28 | 30.98% |
2015 | 4.03 | 115.75% |
2014 | 1.87 | -3.32% |
2013 | 1.93 | 25.58% |
2012 | 1.54 | -2.64% |
2011 | 1.58 | -15.41% |
2010 | 1.87 | 21.22% |
2009 | 1.54 | 107.96% |
2008 | 0.7415 | -67.54% |
2007 | 2.28 | -13.67% |
2006 | 2.65 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Baxter BAX | 1.35 | -81.40% | ๐บ๐ธ USA |
Boston Scientific BSX | 6.96 | -4.20% | ๐บ๐ธ USA |
Edwards Lifesciences EW | 8.67 | 19.29% | ๐บ๐ธ USA |
Teleflex TFX | 3.28 | -54.80% | ๐บ๐ธ USA |
AngioDynamics ANGO | 0.7566 | -89.59% | ๐บ๐ธ USA |
Cardiovascular Systems CSII | 3.52 | -51.56% | ๐บ๐ธ USA |